1887

Abstract

The cellular immune response of seven rhesus macaques immunized with Tween-ether-treated macaque strain of simian immunodeficiency virus (SIV) and three non-vaccinated control animals was investigated. Immunization elicited antigen-specific proliferating CD4 cells in five of seven monkeys. Proliferating T cells were found in all animals protected from a first virus challenge. Cytotoxic T lymphocytes (CTLs) were not induced by the immunization. After the second challenge, the four formerly protected animals became infected, despite a strong proliferative CD4 cell activity in three of them. All animals lost their proliferative activity 2 weeks after infection. After the first challenge four of the six infected animals exhibited a CTL response and after the second challenge, one of four newly infected macaques acquired a CTL response. The five animals with a CTL activity against SIV proteins were protected from severe thrombo-cytopenia, which appeared in the five CTL-negative animals after infection. Our data show the induction of proliferative T cells by immunization with soluble SIV antigen. This T cell reactivity was found in all animals protected from the first virus challenge, but did not confer protection from the second challenge. Interestingly, the proliferative T cell reactivity disappeared 2 weeks after virus infection. Furthermore a CTL response against viral proteins seems to protect infected animals from severe thrombocytopenia which is an early sign of AIDS in monkeys.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-73-9-2273
1992-09-01
2023-02-05
Loading full text...

Full text loading...

/deliver/fulltext/jgv/73/9/JV0730092273.html?itemId=/content/journal/jgv/10.1099/0022-1317-73-9-2273&mimeType=html&fmt=ahah

References

  1. Achour A., Picard O., Zagury D., Sarin P. S., Gallo R. C., Naylor P. H., Goldstein A. L. 1990; HGP30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proceedings of the National Academy of Sciences U.S.A. 87:7045–7049
    [Google Scholar]
  2. Ahearne P. M., Matthews T. J., Lyerly H. K., White G. C., Bolognesi D. P., Weinhold K. J. 1988; Cellular immune response to viral peptides in patients exposed to HIV. AIDS Research and Human Retroviruses 4:259–267
    [Google Scholar]
  3. Ahmed-Ansari A., Powell J. D., Jensen P. E., Yehuda-Cohen T., McClure H. M., Anderson D., Fultz P. N., Sell K. W. 1990; Requirements for simian immunodeficiency virus antigen-specific in vitro proliferation of T cells from infected rhesus macaques and sooty mangabeys. AIDS 4:399–407
    [Google Scholar]
  4. Berzofsky J. A., Bensussan A., Cease K. B., Bourge J. F., Cheynier R., Lurhuma Z., Salaün J.-J., Gallo R. C., Shearer G. M., Zagury D. 1988; Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans. Nature, London 334:706–708
    [Google Scholar]
  5. Carlson J. R., McGraw T. P., Keddie E., Yee J. L., Rosenthal A., Langlois A. J., Dickover R., Donovan R., Luciw P. A., Jennings M. B., Gardner M. B. 1990; Vaccine protection of rhesus macques against simian immunodeficiency virus infection. AIDS Research and Human Retroviruses 6:1239–1246
    [Google Scholar]
  6. Chenciner N., Michel F., Dadaglio G., Langlade-Demoyen P., Hoffenbach A., Leroux A., Garcia-Pons F., Rautmann G., Guy B., Guillon J.-M., Mayaud C., Girard M., Autran B., Kieny M.-P., Plata F. 1989; Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice. European Journal of Immunology 19:1537–1544
    [Google Scholar]
  7. Clerici M., Lucey D. R., Zajac R. A., Boswell R. N., Gebel H. M., Takahashi H., Berzofsky J. A., Shearer G. M. 1991; Detection of cytotoxic T lymphocytes specific for synthetic peptides of gpl60 in HIV-seropositive individuals. Journal of Immunology 146:2214–2219
    [Google Scholar]
  8. Cranage M. P., Cook N., Johnstone P., Greenaway P. J., Kitchin P. A., Stott E. J., Almond N., Baskerville A. 1990; SIV infection of rhesus macaques: in vitro titration of infectivity and development of an experimental vaccine. In Animal Models in AIDS pp 103–114 Edited by Schellekens H., Horzinek M. C. Amsterdam: Elsevier;
    [Google Scholar]
  9. Culmann B., Gomard E., Kieny M.-P., Guy B., Dreyfus F., Saimot A.-G., Serini D., Sicard D., Levy J.-P. 1991; Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV1 nef protein. Journal of Immunology 146:1560–1565
    [Google Scholar]
  10. Daniel M. D., Letvin N. L., King N. W., Kannagi M., Sehgal P. K., Hunt R. D., Kanki P. J., Essex M. F., Desrosiers R. C. 1985; Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science 228:1201–1204
    [Google Scholar]
  11. Desrosiers R. C., Wyand M. S., Kodama T., Ringler D. J., Arthur L. O., Sehgal P. K., Letvin N. L., King N. W., Daniel M. D. 1989; Vaccine protection against simian immunodeficiency virus infection. Proceedings of the National Academy of Sciences U.S.A. 86:6353–6357
    [Google Scholar]
  12. Dormont D., Livartowsky J., Chamaret S., Guétard D., Henin D, Levagueresse R., van de Moortelle P. F., Larke B., Gourmelon P., Vazeaux R., Metivier H., Flageat J., Court L., Hauw J. J., Montagnier L. 1989; HIV-2 in rhesus monkeys: serological, virological and clinical results. Intervirology 30:59–65
    [Google Scholar]
  13. Earl P. L., Koenig S., Moss B. 1991; Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses. Journal of Virology 65:31–41
    [Google Scholar]
  14. Eichberg J. W., Zarling J. M., Alter H. J., Levy J. A., Berman P. W., Gregory T., Lasky L. A., McClure J., Cobb K. E., Moran P. A., Hu S.-L., Kennedy R. C., Chanh T. C., Dreesman G. R. 1987; T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees. Journal of Virology 61:3804–3808
    [Google Scholar]
  15. Gotch F. M., Kelly C., Ellis S. A., Wallace L., Rickinson A. B., van der Poel J., Crumpton M. J., Mcmichael A. J. 1985; Characterization of the HLA A2.2 subtype. T cell evidence for further heterogeneity. Immunogenetics 21:11–23
    [Google Scholar]
  16. Gotch F. M., Nixon D. F., Alp N., McMichael A., Borysiewicz L. K. 1990; High frequency of memory and effector gag-specific cytotoxic T lymphocytes in HIV-seropositive individual. International Immunology 2:707–712
    [Google Scholar]
  17. Gotch F. M., Hovell R., Delchambre M., Silvera P., McMichael M. 1991; Cytotoxic T cell response to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. AIDS 5:317–320
    [Google Scholar]
  18. Grabstein K., Chen Y. U. 1980; Cell-mediated cytolytic responses. In Selected Methods in Cellular Immunology pp 128137 Edited by Mishell B. B., Shiigi S. M. San Francisco: Freeman;
    [Google Scholar]
  19. Hammond S. A., Obah E., Stanhope P., Monell C. R., Strand M., Robbins F. M., Bias W. B., Karr R. W., Koenig S., Siliciano R. F. 1991; Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccineinduced human cytolytic T cells. Journal of Immunology 146:1470–1477
    [Google Scholar]
  20. Hoffenbach A., Landlade-Demoyen P., Dadaglio G., Vilmer D., Michel F., Mayaud C., Autran B., Plata F. 1989; Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. Journal of Immunology 142:452–462
    [Google Scholar]
  21. Hosmalin A., Clerici M., Houghten R., Pendleton C. D., Flexner C., Lucey D. R., Moss B., Germain R. N., Shearer G. M., Berzofsky J. A. 1990; An epitope in human immunodeficiency virus 1 reverse transcriptase recognized by both mouse and human cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences U.S.A. 87:2344–2348
    [Google Scholar]
  22. Hu S.-L, Abrams K., Barber G. N., Moran P., Zarling J. M., Langlois A. J., Kuller L., Morton W. R., Benveniste R. E. 1992; Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60. Science 255:456–459
    [Google Scholar]
  23. Kannagi M., Chalifoux L. V., Lord C. I., Letvin N. L. 1988; Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. Journal of Immunology 140:2237–2242
    [Google Scholar]
  24. Kannagi M., Masuda T., Hattori T., Kanoh T., Nasu K., Yamamoto N., Harada S. 1990; Interference with human immunodeficiency virus (HIV) replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. Journal of Virology 64:3399–3406
    [Google Scholar]
  25. Karpatkin S. 1990; HIV-l-related thrombocytopenia. Hematology and Oncology Clinics of North America 4:193–218
    [Google Scholar]
  26. Koenig S., Earl P., Powell D., Pantaleo G., Merli S., Moss B., Fauci A. S. 1988; Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-l-infected individual. Proceedings of the National Academy of Sciences, U.S.A. 85:8638–8642
    [Google Scholar]
  27. Koenig S., Fuerst T. R., Wood L. V., Woods R. M., Suzich J. A., Jones G. M., de la Cruz V. F., Davey R. T., Venkatesan S., Moss B., Biddison W. E., Fauci A. S. 1990; Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein. Journal of Immunology 145:127–135
    [Google Scholar]
  28. Kornfeld H., Riedel N., Viglianti G. A., Hirsch V., Mullins J. I. 1987; Cloning of HTLV-IV and its relation to simian and human immunodeficiency viruses. Nature, London 326:610–613
    [Google Scholar]
  29. Langlade-Demoyen P., Michel F., Hoffenbach A., Vilmer E., Dadaglio G., Garcia-Pons F., Mayaud C., Autran B., Wain-Hobson S., Plata F. 1988; Immune recognition of AIDS virus antigens by human and murine cytotoxic T lymphocytes. Journal of Immunology 141:1949–1957
    [Google Scholar]
  30. Le Grand R., Vaslin B., Vogt G., Roques P., Humbert M., Dormont D., Aubertin A. M. 1992; AIDS vaccine developments. Nature, London 355:684
    [Google Scholar]
  31. Letvin N. L., Daniel M. D., Sehgal P. K., Desrosiers R. C., Hunt R. D., Waldron L. M., MacKey J. J., Schmidt D. K., Chalifoux L. V., King N. W. 1985; Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230:71–73
    [Google Scholar]
  32. Littaua R. A., Oldstone M. B. A., Takeda A., Debouck C., Wong J. T., Tuazon C. U., Moss B., Kievits F., Ennis F. A. 1991; An HLA-C-restricted CD8+ cytotoxic T-lymphocyte clone recognizes a highly conserved epitope on human immunodeficiency virus type 1 gag. Journal of Virology 65:4051–4056
    [Google Scholar]
  33. McGraw T. P., Vowels B. R., Gardner M. B., Ahmed-Ansari A., Gershwin M. E. 1990; Simian immunodeficiency virus-specific T cell-mediated proliferative response of infected rhesus macaques. AIDS 4:191–198
    [Google Scholar]
  34. Mannhalter J. W., Pum M., Wolf H. M., Kupcu Z., Barrett N., Dorner F., Eder G., Eibl M. M. 1991; Immunization of chimpanzees with the HIV-1 glycoprotein gpl60 induces long-lasting T-cell memory. AIDS Research and Human Retroviruses 7:485–492
    [Google Scholar]
  35. Martin L. N., Gormus B. J., Bozelka B. E. 1983; Functional analysis of monkey lymphocyte subsets defined by OKT4 and OKT8 monoclonal antibodies. Cellular Immunology 77:338–347
    [Google Scholar]
  36. Miller M. D., Lord C. I., Stallard V., Mazzara G. P., Letvin N. L. 1990; The gag-specific cytotoxic T lymphocytes in rhesus monkeys infected with the simian immunodeficiency virus of macaques. Journal of Immunology 144:122–128
    [Google Scholar]
  37. Mills K. H. G., Kitchin P. A., Mahon B. P., Barnard A. L., Adams S. E., Kingsman S. M., Kingsman A. J. 1990; HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1. Journal of Immunology 144:16771683
    [Google Scholar]
  38. Murphey-Corb M., Martin L. N., Davison-Fairburn B., Montelaro R., Miller M., West M., Ohkawa S., Baskin G. B., Zhang J. Y., Putney S., Allison A. C., Eppstein D. 1989; A formalin-inactivated whole SIV vaccine confers protection in macaques. Science 246:1293–1297
    [Google Scholar]
  39. Nixon D. F., Townsend A. R. M., Elvin J. G., Rizza C. R., Gallwey J., McMichael A. J. 1988; HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature, London 336:484–487
    [Google Scholar]
  40. Nixon D. F., Huet S., Rothbard J., Kieny M.-P., Delchambre M., Thiriart C., Rizza C. R., Gotch F. M., McMichael A. J. 1990; An HIV-1 and HIV-2 cross-reactive cytotoxic T cell epitope. AIDS 4:841–845
    [Google Scholar]
  41. Orentas R. J., Hildreth J. E. K., Obah E., Polydefkis M., Smith G. E., Clements M. L., Siliciano R. F. 1990; Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gpl60 subunit vaccine. Science 248:1234–1237
    [Google Scholar]
  42. Osterhaus A., De Vries P., Heeney J. 1992; AIDS vaccine development. Nature, London 355:684–685
    [Google Scholar]
  43. Parham P., Barnstable C. J., Bodmer W. F. 1979; Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C-antigens. Journal of Immunology 123:342–349
    [Google Scholar]
  44. Plata F., Autran B., Martins L. P., Wain-Hobson S., Raphael M., Mayaud C., Denis M., Guillon J.-M., Debre P. 1987; AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature, London 328:348–351
    [Google Scholar]
  45. Putkonen P., Bottiger B., Warstedt K., Thorstensson R., Albert J., Biberfeld G. 1989; Experimental infection of cynomolgus monkeys (Macaca fascicularis) with HIV-2. Journal of AIDS 2:366–373
    [Google Scholar]
  46. Putkonen P., Thorstensson R., Walther L., Albert J., Akerblom L., Granquist O., Wadell G., Norrby E., Biberfeld G. 1991; Vaccine protection against HIV-2 infection in cynomolgus monkeys. AIDS Research and Human Retroviruses 7:271–277
    [Google Scholar]
  47. Rabin H., Neubauer R., Hopkins R., Dzhikidze E., Shevtsova Z., Lapin B. 1977; Transforming activity and antigenicity of an Epstein-Barr-like virus from lymphoblastoid cell lines of baboons with lymphoid disease. Intervirology 8:240–249
    [Google Scholar]
  48. Riviere Y., Tanneau-Salvadori F., Regnault A., Lopez O., Sansonetti P., Guy B., Kieny M.-P., Fournel J.-J., Montagnier L. 1989; Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals: distinct types of effector cells mediate killing of targets expressing gag and env proteins. Journal of Virology 63:2270–2277
    [Google Scholar]
  49. Samstag Y., Bader A., Meuer S. 1991; A serine phosphatase is involved in CD2-mediated activation of human T lymphocytes and NK cells. Journal of Immunology 147:788–794
    [Google Scholar]
  50. Schrier R. D., Gnann J. W., Langlois A. J., Shriver K., Nelson J. A., Oldstone M. B. A. 1988; B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus. Journal of Virology 62:2531–2536
    [Google Scholar]
  51. Schrier R. D., Gnann J. W., Landes R., Lockshin C., Richman D., McCutchan A., Kennedy C., Oldstone M. B. A., Nelson J. A. 1989; T cell recognition of HIV synthetic peptides in a natural infection. Journal of Immunology 142:1166–1176
    [Google Scholar]
  52. Shepp D. H., Daguillard F., Mann D., Quinnan G. V. 1988; Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens. AIDS 2:113–117
    [Google Scholar]
  53. Stahl-Hennig C., Herchenroder O., Nick S., Evers M., Stille-Siegener M., Jentsch K-D., Kirchhoff K., Tolle T., Gatesman T. J., Luke W., Hunsmann G. 1990; Experimental infection of macaques with HIV-2BEN, a novel HIV-2 isolate. AIDS 4:611–617
    [Google Scholar]
  54. Stahl-Hennig C., Voss G., Nick S., Petry H., Fuchs D., Wachter H., Coulibaly C., Luke W., Hunsmann G. 1992; Immunization with Tweenether treated SIV adsorbed onto aluminium hydroxide protects monkeys against experimental SIV infection. Virology 186:588–596
    [Google Scholar]
  55. Stott E. J., Kitchin P. A., Page M., Flanagan B., Taffs L. F., Chan W. L., Mills K. H. G., Silvera P., Rodgers A. 1991; Anti-cell antibody in macaques. Nature, London 353:393
    [Google Scholar]
  56. Takahashi H., Takeshita T., Morein B., Putney S., Germain R. N., Berzofsky J. A. 1990; Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature, London 344:873–875
    [Google Scholar]
  57. Tsubota H., Lord C. I., Watkins D. I., Morimoto C., Letvin N. L. 1989; A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. Journal of Experimental Medicine 169:1421–1434
    [Google Scholar]
  58. Wahren B., Morfeldt-Mansson L., Biberfeld G., Moberg L., Sonnerborg A., Ljundman P., Werner A., Kurth R., Gallo R., Bolognesi D. 1987; Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. Journal of Virology 61:2017–2023
    [Google Scholar]
  59. Walker B. D., Chakrabarti S., Moss B., Paradis T. J., Flynn T., Durno A. G., Blumberg R. S., Kaplan J. C., Hirsch M. S., Schooley R. T. 1987; HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature, London 328:345–348
    [Google Scholar]
  60. Walker B. D., Flexner C., Paradis R. M., Fuller T. C., Hirsch M. S., Schooley R. T., Moss B. 1988; HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science 240:64–66
    [Google Scholar]
  61. Walker B. D., Flexner C., Birch-Limberger K., Fisher L., Paradis T. J., Aldovini A., Young R., Moss B., Schooley R. T. 1989; Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, U.S.A. 86:9514–9518
    [Google Scholar]
  62. Weinhold K. J., Lyerly H. K., Matthews T. J., Tyler D. S., Ahearne P. M., Stine K. C., Langlois A. J., Durack D. T., Bolognesi D. P. 1988; Cellular anti-gpl20 cytolytic reactivities in HIV-1 seropositive individuals. Lancet i:902–905
    [Google Scholar]
  63. Yamamoto H., Miller M. D., Tsubota H., Watkins D. I., Mazzara G. P., Stallard V., Panicali D. L., Aldovini A., Young R. A., Letvin N. L. 1990a; Studies of cloned simian immunodeficiency virus-specific T lymphocytes. Journal of Immunology 144:3385–3391
    [Google Scholar]
  64. Yamamoto H., Miller M. D., Watkins D. I., Snyder G. B., Chase N. E., Mazzara G. P., Gritz L., Panicali D. L., Letvin N. L. 1990b; Two distinct lymphocyte populations mediate simian immunodeficiency virus envelope-specific target cell lysis. Journal of Immunology 145:3740–3746
    [Google Scholar]
  65. Zarling J. M., Eichberg J. W., Moran P. A., McClure J., Sridhar P., Hu S.-L. 1987; Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. Journal of Immunology 139:988–990
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-73-9-2273
Loading
/content/journal/jgv/10.1099/0022-1317-73-9-2273
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error